Hacker News new | ask | show | jobs
by L_Rahman 3193 days ago
Given the entrenched nature of the American pharmaceutical industry, I'm unconvinced that any of them have actually tried to solve the problem of cheap antibody manufacturing at scale.
1 comments

Why wouldn't they? Any reduction in cost is pure profit for them.
Reflexive paranoia rather than calm business analysis tends to rule the day when pharmaceutical companies are under consideration.